Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Morphometric correlates of anomia in patients with small left temporopolar lesions.

Alemán-Gómez Y, Poch C, Toledano R, Jiménez-Huete A, García-Morales I, Gil-Nagel A, Campo P.

J Neuropsychol. 2019 May 6. doi: 10.1111/jnp.12184. [Epub ahead of print]

PMID:
31059211
2.

Ascertaining the epidemiology, patient flow and disease management for Dravet syndrome in Spain.

Gil-Nagel A, Sanchez-Carpintero R, San Antonio V, Mistry A, Barker G, Shepherd J, Gil A.

Rev Neurol. 2019 Jan 16;68(2):75-81. Spanish, English.

3.

[«Apuntes en Neurologia» (Notes in Neurology): a synthesis of the evidence on common paroxysmal neurological disorders and on neurodegenerative disorders].

Toledo M, Carnero-Pardo C, Carreno-Martinez M, Escudero-Torrella J, Gaig C, Garcia-Ribas G, Gil-Nagel A, Grandas FJ, Kulisevsky J, Lainez-Andres JM, Pareja JA, Porta-Etessam J, Poza-Aldea JJ, Rodriguez-Oroz MC, Serratosa JM, Villanueva V.

Rev Neurol. 2018 Nov 26;67(s01):S1-S21. Review. Spanish.

PMID:
30484273
4.

Genetic (idiopathic) generalized epilepsy with occipital semiology.

Gómez-Porro P, Aledo-Serrano A, Toledano R, García-Morales I, Gil-Nagel A.

Epileptic Disord. 2018 Oct 1;20(5):434-439. doi: 10.1684/epd.2018.0994.

PMID:
30361187
5.

Retrospective study of perampanel efficacy and tolerability in myoclonic seizures.

Gil-López FJ, Montoya J, Falip M, Aparicio J, López-González FJ, Toledano R, Gil-Nagel A, Molins A, García I, Serrano P, Domenech G, Torres F, Donaire A, Carreño M.

Acta Neurol Scand. 2018 Aug;138(2):122-129. doi: 10.1111/ane.12931. Epub 2018 Mar 24.

PMID:
29573400
6.

The Surgical Approach to the Anterior Nucleus of Thalamus in Patients With Refractory Epilepsy: Experience from the International Multicenter Registry (MORE).

Lehtimäki K, Coenen VA, Gonçalves Ferreira A, Boon P, Elger C, Taylor RS, Ryvlin P, Gil-Nagel A, Gielen F, Brionne TC, Abouihia A, Beth G; MORE investigators.

Neurosurgery. 2019 Jan 1;84(1):141-150. doi: 10.1093/neuros/nyy023.

PMID:
29554309
7.

Epidemiological profile of epilepsy in low income populations.

Espinosa-Jovel C, Toledano R, Aledo-Serrano Á, García-Morales I, Gil-Nagel A.

Seizure. 2018 Mar;56:67-72. doi: 10.1016/j.seizure.2018.02.002. Epub 2018 Feb 8. Review.

8.

Specificity of electroclinical features in the diagnosis of ring chromosome 20.

Gago-Veiga AB, Toledano R, García-Morales I, Pérez-Jiménez MA, Bernar J, Gil-Nagel A.

Epilepsy Behav. 2018 Mar;80:215-220. doi: 10.1016/j.yebeh.2017.12.001. Epub 2018 Feb 3.

PMID:
29414555
9.

A retrospective, multicentre study of perampanel given as monotherapy in routine clinical care in people with epilepsy.

Gil-Nagel A, Burd S, Toledo M, Sander JW, Lebedeva A, Patten A, Laurenza A; Study 504 investigator group.

Seizure. 2018 Jan;54:61-66. doi: 10.1016/j.seizure.2017.10.015. Epub 2017 Oct 18.

10.

Histopathological Findings in Brain Tissue Obtained during Epilepsy Surgery.

Blumcke I, Spreafico R, Haaker G, Coras R, Kobow K, Bien CG, Pfäfflin M, Elger C, Widman G, Schramm J, Becker A, Braun KP, Leijten F, Baayen JC, Aronica E, Chassoux F, Hamer H, Stefan H, Rössler K, Thom M, Walker MC, Sisodiya SM, Duncan JS, McEvoy AW, Pieper T, Holthausen H, Kudernatsch M, Meencke HJ, Kahane P, Schulze-Bonhage A, Zentner J, Heiland DH, Urbach H, Steinhoff BJ, Bast T, Tassi L, Lo Russo G, Özkara C, Oz B, Krsek P, Vogelgesang S, Runge U, Lerche H, Weber Y, Honavar M, Pimentel J, Arzimanoglou A, Ulate-Campos A, Noachtar S, Hartl E, Schijns O, Guerrini R, Barba C, Jacques TS, Cross JH, Feucht M, Mühlebner A, Grunwald T, Trinka E, Winkler PA, Gil-Nagel A, Toledano Delgado R, Mayer T, Lutz M, Zountsas B, Garganis K, Rosenow F, Hermsen A, von Oertzen TJ, Diepgen TL, Avanzini G; EEBB Consortium.

N Engl J Med. 2017 Oct 26;377(17):1648-1656. doi: 10.1056/NEJMoa1703784.

11.

Pooled efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Data from four double-blind placebo-controlled pivotal phase III clinical studies.

Elger C, Koepp M, Trinka E, Villanueva V, Chaves J, Ben-Menachen E, Kowacs PA, Gil-Nagel A, Moreira J, Gama H, Rocha JF, Soares-da-Silva P.

CNS Neurosci Ther. 2017 Dec;23(12):961-972. doi: 10.1111/cns.12765. Epub 2017 Oct 13.

12.

Lacosamide for refractory generalized tonic-clonic seizures of non-focal origin in clinical practice: A clinical and VEEG study.

Abarrategui B, García-García ME, Toledano R, Parejo-Carbonell B, Gil-Nagel A, García-Morales I.

Epilepsy Behav Case Rep. 2017 Aug 24;8:63-65. doi: 10.1016/j.ebcr.2017.08.001. eCollection 2017.

13.

Practice Guideline Summary: Sudden Unexpected Death in Epilepsy Incidence Rates and Risk Factors: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Harden C, Tomson T, Gloss D, Buchhalter J, Cross JH, Donner E, French JA, Gil-Nagel A, Hesdorffer DC, Smithson WH, Spitz MC, Walczak TS, Sander JW, Ryvlin P.

Epilepsy Curr. 2017 May-Jun;17(3):180-187. doi: 10.5698/1535-7511.17.3.180.

14.

Efficacy and safety of eslicarbazepine acetate monotherapy for partial-onset seizures: Experience from a multicenter, observational study.

Toledano R, Jovel CE, Jiménez-Huete A, Bayarri PG, Campos D, Gomariz EL, Giráldez BG, García-Morales I, Falip M, Agredano PM, Palao S, Prior MJAA, Pascual MRQ, Navacerrada FJ, González FJL, Ojeda J, Sáez AA, Bermejo PE, Gil-Nagel A.

Epilepsy Behav. 2017 Aug;73:173-179. doi: 10.1016/j.yebeh.2017.02.028. Epub 2017 Jun 20.

PMID:
28641170
15.

Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Harden C, Tomson T, Gloss D, Buchhalter J, Cross JH, Donner E, French JA, Gil-Nagel A, Hesdorffer DC, Smithson WH, Spitz MC, Walczak TS, Sander JW, Ryvlin P.

Neurology. 2017 Apr 25;88(17):1674-1680. doi: 10.1212/WNL.0000000000003685.

PMID:
28438841
16.

Current standards of neuropsychological assessment in epilepsy surgery centers across Europe.

Vogt VL, Äikiä M, Del Barrio A, Boon P, Borbély C, Bran E, Braun K, Carette E, Clark M, Cross JH, Dimova P, Fabo D, Foroglou N, Francione S, Gersamia A, Gil-Nagel A, Guekht A, Harrison S, Hecimovic H, Heminghyt E, Hirsch E, Javurkova A, Kälviäinen R, Kavan N, Kelemen A, Kimiskidis VK, Kirschner M, Kleitz C, Kobulashvili T, Kosmidis MH, Kurtish SY, Lesourd M, Ljunggren S, Lossius MI, Malmgren K, Mameniskiené R, Martin-Sanfilippo P, Marusic P, Miatton M, Özkara Ç, Pelle F, Rubboli G, Rudebeck S, Ryvlin P, van Schooneveld M, Schmid E, Schmidt PM, Seeck M, Steinhoff BJ, Shavel-Jessop S, Tarta-Arsene O, Trinka E, Viggedal G, Wendling AS, Witt JA, Helmstaedter C; E-PILEPSY consortium.

Epilepsia. 2017 Mar;58(3):343-355. doi: 10.1111/epi.13646. Epub 2017 Jan 9.

17.

Serial arterial spin labeling MRI in autonomic status epilepticus due to anti-LGI1 encephalitis.

Espinosa-Jovel C, Toledano R, García-Morales I, Álvarez-Linera J, Gil-Nagel A.

Neurology. 2016 Jul 26;87(4):443-4. doi: 10.1212/WNL.0000000000002903. No abstract available.

PMID:
27462038
18.

Testing patients during seizures: A European consensus procedure developed by a joint taskforce of the ILAE - Commission on European Affairs and the European Epilepsy Monitoring Unit Association.

Beniczky S, Neufeld M, Diehl B, Dobesberger J, Trinka E, Mameniskiene R, Rheims S, Gil-Nagel A, Craiu D, Pressler R, Krysl D, Lebedinsky A, Tassi L, Rubboli G, Ryvlin P.

Epilepsia. 2016 Sep;57(9):1363-8. doi: 10.1111/epi.13472. Epub 2016 Jul 21.

19.

A fast pathway for fear in human amygdala.

Méndez-Bértolo C, Moratti S, Toledano R, Lopez-Sosa F, Martínez-Alvarez R, Mah YH, Vuilleumier P, Gil-Nagel A, Strange BA.

Nat Neurosci. 2016 Aug;19(8):1041-9. doi: 10.1038/nn.4324. Epub 2016 Jun 13.

PMID:
27294508
20.

Current practices in long-term video-EEG monitoring services: A survey among partners of the E-PILEPSY pilot network of reference for refractory epilepsy and epilepsy surgery.

Kobulashvili T, Höfler J, Dobesberger J, Ernst F, Ryvlin P, Cross JH, Braun K, Dimova P, Francione S, Hecimovic H, Helmstaedter C, Kimiskidis VK, Lossius MI, Malmgren K, Marusic P, Steinhoff BJ, Boon P, Craiu D, Delanty N, Fabo D, Gil-Nagel A, Guekht A, Hirsch E, Kalviainen R, Mameniskiené R, Özkara Ç, Seeck M, Rubboli G, Krsek P, Rheims S, Trinka E.

Seizure. 2016 May;38:38-45. doi: 10.1016/j.seizure.2016.03.009. Epub 2016 Apr 1.

21.

Small temporal pole encephalocele: A hidden cause of "normal" MRI temporal lobe epilepsy.

Toledano R, Jiménez-Huete A, Campo P, Poch C, García-Morales I, Gómez Angulo JC, Coras R, Blümcke I, Álvarez-Linera J, Gil-Nagel A.

Epilepsia. 2016 May;57(5):841-51. doi: 10.1111/epi.13371. Epub 2016 Mar 28.

22.

Current use of imaging and electromagnetic source localization procedures in epilepsy surgery centers across Europe.

Mouthaan BE, Rados M, Barsi P, Boon P, Carmichael DW, Carrette E, Craiu D, Cross JH, Diehl B, Dimova P, Fabo D, Francione S, Gaskin V, Gil-Nagel A, Grigoreva E, Guekht A, Hirsch E, Hecimovic H, Helmstaedter C, Jung J, Kalviainen R, Kelemen A, Kimiskidis V, Kobulashvili T, Krsek P, Kuchukhidze G, Larsson PG, Leitinger M, Lossius MI, Luzin R, Malmgren K, Mameniskiene R, Marusic P, Metin B, Özkara C, Pecina H, Quesada CM, Rugg-Gunn F, Rydenhag B, Ryvlin P, Scholly J, Seeck M, Staack AM, Steinhoff BJ, Stepanov V, Tarta-Arsene O, Trinka E, Uzan M, Vogt VL, Vos SB, Vulliémoz S, Huiskamp G, Leijten FS, Van Eijsden P, Braun KP; E-PILEPSY consortium.

Epilepsia. 2016 May;57(5):770-6. doi: 10.1111/epi.13347. Epub 2016 Mar 25.

23.

Differences in visual naming performance between patients with temporal lobe epilepsy associated with temporopolar lesions versus hippocampal sclerosis.

Poch C, Toledano R, Jiménez-Huete A, García-Morales I, Gil-Nagel A, Campo P.

Neuropsychology. 2016 Oct;30(7):841-52. doi: 10.1037/neu0000269. Epub 2016 Feb 22.

PMID:
26901171
24.

Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Frontal Lobe Epilepsy: A New Clinico-Pathological Entity.

Schurr J, Coras R, Rössler K, Pieper T, Kudernatsch M, Holthausen H, Winkler P, Woermann F, Bien CG, Polster T, Schulz R, Kalbhenn T, Urbach H, Becker A, Grunwald T, Huppertz HJ, Gil-Nagel A, Toledano R, Feucht M, Mühlebner A, Czech T, Blümcke I.

Brain Pathol. 2017 Jan;27(1):26-35. doi: 10.1111/bpa.12347. Epub 2016 Feb 22.

PMID:
26748554
25.

Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.

Biton V, Gil-Nagel A, Isojarvi J, Doty P, Hebert D, Fountain NB.

Epilepsy Behav. 2015 Nov;52(Pt A):119-27. doi: 10.1016/j.yebeh.2015.09.006. Epub 2015 Sep 27.

26.

Immunomodulated parkinsonism as a presenting symptom of LGI1 antibody encephalitis.

Kurtis MM, Toledano R, García-Morales I, Gil-Nagel A.

Parkinsonism Relat Disord. 2015 Oct;21(10):1286-7. doi: 10.1016/j.parkreldis.2015.08.014. Epub 2015 Aug 18. No abstract available.

PMID:
26320889
27.

Long-term efficacy and safety of lacosamide monotherapy in the treatment of partial-onset seizures: A multicenter evaluation.

Giráldez BG, Toledano R, García-Morales I, Gil-Nagel A, López-González FJ, Tortosa D, Ojeda J, Serratosa JM.

Seizure. 2015 Jul;29:119-22. doi: 10.1016/j.seizure.2015.04.003. Epub 2015 Apr 23.

28.

Altered brain rhythms and functional network disruptions involved in patients with generalized fixation-off epilepsy.

Solana AB, Martínez K, Hernández-Tamames JA, San Antonio-Arce V, Toledano R, García-Morales I, Alvárez-Linera J, Gil-Nágel A, Del Pozo F.

Brain Imaging Behav. 2016 Jun;10(2):373-86. doi: 10.1007/s11682-015-9404-6.

PMID:
26001771
29.

Time to prerandomization monthly seizure count in perampanel trials: A novel epilepsy endpoint.

French JA, Gil-Nagel A, Malerba S, Kramer L, Kumar D, Bagiella E.

Neurology. 2015 May 19;84(20):2014-20. doi: 10.1212/WNL.0000000000001585. Epub 2015 Apr 15.

30.

A European survey on current practices in epilepsy monitoring units and implications for patients' safety.

Rubboli G, Beniczky S, Claus S, Canevini MP, Kahane P, Stefan H, van Emde Boas W, Velis D, Reus E, Gil-Nagel A, Steinhoff BJ, Trinka E, Ryvlin P.

Epilepsy Behav. 2015 Mar;44:179-84. doi: 10.1016/j.yebeh.2015.02.004. Epub 2015 Feb 26.

PMID:
25725329
31.

Prevalence of depressive symptoms and their impact on quality of life in patients with drug-resistant focal epilepsy (IMDYVA study).

Garcia ME, Garcia-Morales I, Gil-Nagel A.

Epilepsy Res. 2015 Feb;110:157-65. doi: 10.1016/j.eplepsyres.2014.11.003. Epub 2014 Dec 13.

32.

Visual object naming in patients with small lesions centered at the left temporopolar region.

Campo P, Poch C, Toledano R, Igoa JM, Belinchón M, García-Morales I, Gil-Nagel A.

Brain Struct Funct. 2016 Jan;221(1):473-85. doi: 10.1007/s00429-014-0919-1. Epub 2014 Oct 24.

PMID:
25342238
33.

[Sleep disorders and quality of life in refractory partial epilepsy: results of the SLEEP study].

García-Morales I, Gil-Nagel A, de Rosendo J, Torres-Falcón A.

Rev Neurol. 2014 Feb 16;58(4):152-60. Spanish.

34.

Validity of the clinical and content scales of the Multiphasic Personality Inventory Minnesota 2 for the diagnosis of psychogenic non-epileptic seizures.

del Barrio A, Jiménez-Huete A, Toledano R, García-Morales I, Gil-Nagel A.

Neurologia. 2016 Mar;31(2):106-12. doi: 10.1016/j.nrl.2013.12.006. Epub 2014 Jan 30. English, Spanish.

35.

Safety and tolerability of different titration rates of retigabine (ezogabine) in patients with partial-onset seizures.

Biton V, Gil-Nagel A, Brodie MJ, Derossett SE, Nohria V.

Epilepsy Res. 2013 Nov;107(1-2):138-45. doi: 10.1016/j.eplepsyres.2013.08.021. Epub 2013 Sep 4.

PMID:
24094693
36.

Aphasic seizures in patients with temporopolar and anterior temporobasal lesions: a video-EEG study.

Toledano R, Jiménez-Huete A, García-Morales I, Campo P, Poch C, Strange BA, Gil-Nagel A.

Epilepsy Behav. 2013 Oct;29(1):172-7. doi: 10.1016/j.yebeh.2013.07.017. Epub 2013 Aug 22.

PMID:
23973642
37.

Anterobasal temporal lobe lesions alter recurrent functional connectivity within the ventral pathway during naming.

Campo P, Poch C, Toledano R, Igoa JM, Belinchón M, García-Morales I, Gil-Nagel A.

J Neurosci. 2013 Jul 31;33(31):12679-88. doi: 10.1523/JNEUROSCI.0645-13.2013.

38.

Treatment of behavioral problems in intellectually disabled adult patients with epilepsy.

Kerr M, Gil-Nagel A, Glynn M, Mula M, Thompson R, Zuberi SM.

Epilepsia. 2013 Mar;54 Suppl 1:34-40. doi: 10.1111/epi.12103. Review.

39.

Network reconfiguration and working memory impairment in mesial temporal lobe epilepsy.

Campo P, Garrido MI, Moran RJ, García-Morales I, Poch C, Toledano R, Gil-Nagel A, Dolan RJ, Friston KJ.

Neuroimage. 2013 May 15;72:48-54. doi: 10.1016/j.neuroimage.2013.01.036. Epub 2013 Jan 28.

40.

Electroencephalography and video-electroencephalography.

Gil-Nagel A, Abou-Khalil B.

Handb Clin Neurol. 2012;107:323-45. doi: 10.1016/B978-0-444-52898-8.00020-3. Review. No abstract available.

PMID:
22938980
41.

Efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: integrated analysis of pooled data from double-blind phase III clinical studies.

Gil-Nagel A, Elger C, Ben-Menachem E, Halász P, Lopes-Lima J, Gabbai AA, Nunes T, Falcão A, Almeida L, da-Silva PS.

Epilepsia. 2013 Jan;54(1):98-107. doi: 10.1111/j.1528-1167.2012.03605.x. Epub 2012 Aug 6.

42.

Validation of the Spanish version of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E).

Di Capua D, Garcia-Garcia ME, Reig-Ferrer A, Fuentes-Ferrer M, Toledano R, Gil-Nagel A, Garcia-Ptaceck S, Kurtis M, Kanner AM, Garcia-Morales I.

Epilepsy Behav. 2012 Aug;24(4):493-6. doi: 10.1016/j.yebeh.2012.06.005. Epub 2012 Jul 10.

PMID:
22784672
43.

Safety and efficacy of ezogabine (retigabine) in adults with refractory partial-onset seizures: Interim results from two ongoing open-label studies.

Gil-Nagel A, Brodie MJ, Leroy R, Cyr T, Hall S, Castiglia M, Twomey C, VanLandingham K.

Epilepsy Res. 2012 Nov;102(1-2):117-21. doi: 10.1016/j.eplepsyres.2012.05.007. Epub 2012 Jul 5.

PMID:
22771137
44.

Retigabine as adjunctive therapy in adults with partial-onset seizures: integrated analysis of three pivotal controlled trials.

Porter RJ, Burdette DE, Gil-Nagel A, Hall ST, White R, Shaikh S, DeRossett SE.

Epilepsy Res. 2012 Aug;101(1-2):103-12. doi: 10.1016/j.eplepsyres.2012.03.010. Epub 2012 Apr 16.

PMID:
22512894
45.

Consensus-recommended diagnostic and therapeutic guidelines for drug-resistant epilepsy in Spain (Consenso RATE-España).

Sánchez-Álvarez JC, Mauri-Llerda JA, Gil-Nagel A, Casas-Fernández C, Salas-Puig J, Lahuerta J, Sancho-Rieger J; Grupo de Estudio de Epilepsia de la Sociedad Española de Neurología.

Neurologia. 2012 Oct;27(8):481-90. doi: 10.1016/j.nrl.2011.09.006. Epub 2011 Nov 9. English, Spanish.

46.

Drug-resistant epilepsy: current recommendations for diagnosis and treatment in Spain.

Sánchez-Álvarez JC, Gil-Nagel A, Casas-Fernández C, Mauri-Llerda JA, Salas-Puig J, Sancho-Rieger J; Grupo de Estudio de Epilepsia de la Sociedad Española de Neurología.

Neurologia. 2012 Nov-Dec;27(9):575-84. doi: 10.1016/j.nrl.2011.09.005. Epub 2011 Nov 9. English, Spanish.

47.

Early clinical experience with lacosamide as adjunctive therapy in patients with refractory focal epilepsy and nocturnal seizures.

García-Morales I, Delgado RT, Falip M, Campos D, García ME, Gil-Nagel A.

Seizure. 2011 Dec;20(10):801-4. doi: 10.1016/j.seizure.2011.08.005. Epub 2011 Sep 13.

48.

Remote effects of hippocampal sclerosis on effective connectivity during working memory encoding: a case of connectional diaschisis?

Campo P, Garrido MI, Moran RJ, Maestú F, García-Morales I, Gil-Nagel A, del Pozo F, Dolan RJ, Friston KJ.

Cereb Cortex. 2012 Jun;22(6):1225-36. doi: 10.1093/cercor/bhr201. Epub 2011 Aug 1.

49.

Antiepileptic drug therapy: does mechanism of action matter?

Brodie MJ, Covanis A, Gil-Nagel A, Lerche H, Perucca E, Sills GJ, White HS.

Epilepsy Behav. 2011 Aug;21(4):331-41. doi: 10.1016/j.yebeh.2011.05.025. Epub 2011 Jul 16. Review.

PMID:
21763207
50.

Antiepileptic drug therapy: does mechanism of action matter?

Brodie M, Covanis T, Gil-Nagel A, Lerche H, Perucca E, Sills G, White S.

Epilepsy Behav. 2011 Aug;21(4):490; author reply 491. doi: 10.1016/j.yebeh.2011.04.053. Epub 2011 May 31. No abstract available.

PMID:
21622027

Supplemental Content

Loading ...
Support Center